Expert Corner

Faron Pharmaceuticals Share Price Prediction (2025–2030): Expert Analysis & Predictions

Jun 14, 2025 | By Team SR

Faron Pharmaceuticals Share Price Prediction (2025–2030): Expert Analysis & Predictions

Faron Pharmaceuticals is an innovative clinical-stage biopharmaceutical company headquartered in Turku, Finland, and Boston, USA. It’s globally known for developing breakthrough immunotherapies, most notably bexmarilimab, a first-in-class macrophage checkpoint immunotherapy. As investors keep a close watch on the Faron Pharmaceuticals share price forecast, it’s crucial to explore upcoming price trends and expectations.

In this post, we provide a data-driven and expert-supported Faron Pharmaceuticals share price prediction from 2025 to 2030, including monthly projections and trends that could shape the company’s financial trajectory.


About Faron Pharmaceuticals

Founded with the mission to solve unmet medical needs, Faron Pharmaceuticals is advancing cutting-edge therapeutics targeting immune suppression in cancer. Its lead candidate, bexmarilimab, is in Phase I/II clinical trials, targeting hematological malignancies by activating immune responses through its novel anti-Clever-1 mechanism.

Listed under ticker symbols FARN (AIM) and FARON (Nasdaq First North), Faron is gaining investor interest across the UK and Europe.


Current Market (As of Latest Update)

MetricValue
Share Price227.50
Bid220.00
Ask235.00
Spread6.82%
Open/High/Low227.50
Prev. Close227.50
Volume0

Faron Pharmaceuticals Share Price Forecast (2025–2030)

We project the Faron Pharmaceuticals share price forecast using a modest 5% annual growth rate, based on its ongoing research, strategic collaborations, and increasing investor attention. Below is the monthly share price prediction for each year:


Faron Pharmaceuticals Share Price Forecast 2025

MonthPrice (INR)
Jan228.43
Feb229.36
Mar230.29
Apr231.23
May232.17
Jun233.12
Jul234.07
Aug235.02
Sep235.98
Oct236.94
Nov237.91
Dec238.88

Faron Pharmaceuticals Share Price Forecast 2026

MonthPrice (INR)
Jan239.85
Feb240.83
Mar241.81
Apr242.79
May243.78
Jun244.77
Jul245.77
Aug246.77
Sep247.78
Oct248.79
Nov249.80
Dec250.82

Faron Pharmaceuticals Share Price Forecast 2027

MonthPrice (INR)
Jan251.84
Feb252.87
Mar253.90
Apr254.93
May255.97
Jun257.01
Jul258.06
Aug259.11
Sep260.17
Oct261.23
Nov262.29
Dec263.36

Faron Pharmaceuticals Share Price Forecast 2028

MonthPrice (INR)
Jan264.43
Feb265.51
Mar266.59
Apr267.68
May268.77
Jun269.86
Jul270.96
Aug272.07
Sep273.18
Oct274.29
Nov275.41
Dec276.53

Faron Pharmaceuticals Share Price Forecast 2029

MonthPrice (INR)
Jan277.65
Feb278.79
Mar279.92
Apr281.06
May282.21
Jun283.36
Jul284.51
Aug285.67
Sep286.83
Oct288.00
Nov289.18
Dec290.35

Faron Pharmaceuticals Share Price Forecast 2030

MonthPrice (INR)
Jan291.54
Feb292.72
Mar293.92
Apr295.11
May296.32
Jun297.52
Jul298.74
Aug299.95
Sep301.18
Oct302.40
Nov303.63
Dec304.87

Conclusion - Faron Pharmaceuticals Share Price

The Faron Pharmaceuticals share price prediction reflects a stable and optimistic future. As the company advances its clinical trials and regulatory approvals, investor confidence is likely to rise. The upward trend in the Faron Pharmaceuticals share price forecast UK supports this outlook.

However, keep in mind that actual prices may vary due to market conditions, clinical trial results, regulatory announcements, and global economic factors.


FAQs - Faron Pharmaceuticals Share Price

What is the Faron Pharmaceuticals share price forecast for today in the UK?

As per the latest update, the price stands at 227.50, with no change from the previous close.

What is the Faron Pharmaceuticals share price forecast tomorrow?

Based on current patterns, minimal movement is expected unless new announcements or market shifts occur.

Is Faron Pharmaceuticals a good long-term investment?

With its innovative pipeline, especially bexmarilimab, Faron shows strong long-term growth potential. Investors should monitor its clinical updates closely.

How accurate are these forecasts?

These are projections based on historical data and assumed growth rates. Real-world prices depend on many factors, including news, biotech sector trends, and trial results.

Reference:

Google Finance Provides live quote , interactive charts, market cap , P/E ratios, and quarterly financial data https://www.google.com/finance/quote/FARON:HEL?hl=en

Disclaimer:

  • The information is based on our understanding of the stock's historical performance.
  • Stock market predictions are unpredictable and can change, so expert advice is strongly recommended before investing.
  • The values provided are based on predictions and may not be accurate, we recommend verifying the information with other sources.
  • For further inquiries about the stock market, please contact us via email.

Explore more:

Aston Martin Share Price PredictionSolana (SOL) Share Price Forecast
88 Energy Share Price ForecastIAG Share Price Forecast
ITV Share Price ForecastMarks and Spencer Share Price Prediction
NatWest Share Price PredictionInternational Distributions Services Share Price Prediction
BT Group Share Price PredictionBAE Systems Share Price Prediction
HSBC Share Price PredictionOcado Group Share Price Prediction
Avacta Group Share Price PredictionGreatland Gold Share Price Prediction
Burberry Group Share Price PredictionLloyds Banking Group Share Price
Rolls-Royce Holdings Share Price ForecastBarclays Bank Share Price Forecast

Recommended Stories for You